WEBULL
News
NCEL
2.760
-4.50%
-0.130
Weekly Report: what happened at NCEL last week (0202-0206)?
Weekly Report · 2d ago
Weekly Report: what happened at NCEL last week (0126-0130)?
Weekly Report · 02/02 10:05
NewcelX Updates Corporate Presentation as It Sharpens Focus on Type 1 Diabetes Cell Therapies
TipRanks · 01/29 12:28
NewcelX AG Releases Updated Corporate Presentation
Reuters · 01/29 12:02
NewcelX Announces Updated Corporate Presentation Ahead of Key Spring 2026 Investor and Partnering Conferences
PR Newswire · 01/29 12:00
Weekly Report: what happened at NCEL last week (0119-0123)?
Weekly Report · 01/26 10:05
Weekly Report: what happened at NCEL last week (0112-0116)?
Weekly Report · 01/19 10:10
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 01/12 21:05
NewcelX Reports Positive International Study Results on Biomaterial-Based Islet Delivery for Type 1 Diabetes
TipRanks · 01/12 12:27
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 01/12 12:06
NewcelX AG Reports Positive Results from International Study on Stem Cell-Derived Islet Therapy for Type 1 Diabetes
Reuters · 01/12 12:01
NewcelX Announce Positive Results from International Collaborative Study Exploring Advanced Biomaterial Approaches for Stem Cell-Derived Islet Delivery in Type 1 Diabetes Without Immune Suppression
PR Newswire · 01/12 12:00
Weekly Report: what happened at NCEL last week (0105-0109)?
Weekly Report · 01/12 10:09
NewcelX Adds Swiss Diabetes Leader to Advisory Board to Steer IsletRx Program
TipRanks · 01/05 12:47
NewcelX AG Appoints Dr. Julien Boisdron to Scientific Advisory Board
Reuters · 01/05 12:02
Weekly Report: what happened at NCEL last week (1229-0102)?
Weekly Report · 01/05 10:04
Weekly Report: what happened at NCEL last week (1222-1226)?
Weekly Report · 12/29/2025 10:04
Weekly Report: what happened at NCEL last week (1215-1219)?
Weekly Report · 12/22/2025 10:03
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 12/15/2025 21:06
Weekly Report: what happened at NCEL last week (1208-1212)?
Weekly Report · 12/15/2025 10:09
More
Webull provides a variety of real-time NCEL stock news. You can receive the latest news about NewcelX Ltd through multiple platforms. This information may help you make smarter investment decisions.
About NCEL
NewcelX AG, formerly NLS Pharmaceutics AG, is a Switzerland-based company primarily engaged in the biotechnology industry. The Company focuses on the discovery and development of therapies for rare and complex central nervous system (CNS) disorders, including sleep and neurodevelopmental conditions. The Company offers products like Quilience, which is a clinical-stage pharmaceutical compound. It aims to support the treatment of narcolepsy by modulating monoamine neurotransmission and orexin receptor activity. The Company also develops product like Nolazol, a treatment candidate for Attention Deficit Hyperactivity Disorder (ADHD). The Company is a publicly traded company, listing on the NASDAQ.